Advanced cancer patients treated with immune cells that underwent CRISPR-mediated gene editing exhibited no serious side effects, New Scientist reports.
It notes that concerns about the treatment particularly revolved around whether unintended CRISPR cuts occur and turn those cells cancerous as well.